News

Collage of seven teams led by UBC Faculty of Medicine researchers have been awarded new federal funding to accelerate genomics-based health innovations

UBC Medicine researchers receive federal funding to accelerate genomic solutions through industry collaborations

March 19, 2026

Photo of a medical researcher in gloves holding a vial with a syringe

How vaccines give our immune systems a home advantage

March 2, 2026

UBC research associate Dr. Ross Jones in the lab where they are working to develop cell-based therapies from stem cells. Credit: Phillip Chin.

Stem cell engineering breakthrough paves way for next-generation living drugs

January 8, 2026

Close up photo of hands of laboratory worker in gloves holding a vial

Trade and Invest BC: Life Sciences Series: Article 3 – Genomics

January 5, 2026

Provincial funding boosts development of made-in-B.C. medicines

Provincial funding boosts development of made-in-B.C. medicines

December 16, 2025

The B.C. Government announced $33 million for Canada’s Immuno-Engineering and Biomanufacturing Hub as UBC broke ground on its new Advanced Therapeutics Manufacturing Facility.

Picture of AbCellera’s Chief Technology Officer Dr. Veronique Lecault with CEO Dr. Carl Hansen at the company’s Mount Pleasant headquarters., outside on balcony. They are wearing dark blue blazers and light blue shirts.

How AbCellera grew from a UBC lab to a global biotech company

November 28, 2025

Male UBC researcher using a pipette, in a lab wearing blue medical gloves, a medical mask and lab coat

Delivering prosperity, good jobs for B.C., Canada

November 18, 2025

Light purple, white and green banner advertising the RNA & Healthcare Futures Film Screening on November 20 at the SFU Centre for the Arts

Documentary Screening and Panel: RNA and Healthcare Futures

October 31, 2025

Dr. Benoit Antoine Bacon at GVBOT event

The power of partnerships to drive innovation in B.C.

October 23, 2025

Dr. Sriram Subramaniam pictured in his UBC Point Grey lab with colleagues

To pandemic preparedness and beyond: Accelerating novel antibody therapeutics through cross-border collaboration

October 16, 2025